Annual Accounts Payable
$1.22 M
+$608.00 K+99.02%
December 31, 2023
Summary
- As of February 8, 2025, COCP annual accounts payable is $1.22 million, with the most recent change of +$608.00 thousand (+99.02%) on December 31, 2023.
- During the last 3 years, COCP annual accounts payable has risen by +$565.00 thousand (+86.00%).
- COCP annual accounts payable is now -52.73% below its all-time high of $2.58 million, reached on December 31, 2015.
Performance
COCP Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$859.00 K
-$884.00 K-50.72%
September 30, 2024
Summary
- As of February 8, 2025, COCP quarterly accounts payable is $859.00 thousand, with the most recent change of -$884.00 thousand (-50.72%) on September 30, 2024.
- Over the past year, COCP quarterly accounts payable has increased by +$291.00 thousand (+51.23%).
- COCP quarterly accounts payable is now -72.15% below its all-time high of $3.08 million, reached on March 31, 2016.
Performance
COCP Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
COCP Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +99.0% | +51.2% |
| 3 y3 years | +86.0% | +39.9% |
| 5 y5 years | +98.4% | +39.9% |
COCP Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +111.4% | -67.6% | +51.2% |
| 5 y | 5-year | -19.1% | +111.4% | -67.6% | +75.0% |
| alltime | all time | -52.7% | +445.5% | -72.2% | +2306.2% |
Cocrystal Pharma Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $859.00 K(-50.7%) |
| Jun 2024 | - | $1.74 M(+41.2%) |
| Mar 2024 | - | $1.23 M(+1.0%) |
| Dec 2023 | $1.22 M(+99.0%) | $1.22 M(+115.1%) |
| Sep 2023 | - | $568.00 K(-45.4%) |
| Jun 2023 | - | $1.04 M(-60.8%) |
| Mar 2023 | - | $2.65 M(+332.2%) |
| Dec 2022 | $614.00 K(+6.2%) | $614.00 K(-31.5%) |
| Sep 2022 | - | $897.00 K(+45.6%) |
| Jun 2022 | - | $616.00 K(-28.2%) |
| Mar 2022 | - | $858.00 K(+48.4%) |
| Dec 2021 | $578.00 K(-12.0%) | $578.00 K(+17.7%) |
| Sep 2021 | - | $491.00 K(-47.7%) |
| Jun 2021 | - | $939.00 K(+25.5%) |
| Mar 2021 | - | $748.00 K(+13.9%) |
| Dec 2020 | $657.00 K(-56.5%) | $657.00 K(-55.8%) |
| Sep 2020 | - | $1.49 M(+78.5%) |
| Jun 2020 | - | $832.00 K(-9.8%) |
| Mar 2020 | - | $922.00 K(-39.0%) |
| Dec 2019 | $1.51 M(+145.3%) | $1.51 M(+38.4%) |
| Sep 2019 | - | $1.09 M(+2.0%) |
| Jun 2019 | - | $1.07 M(+142.9%) |
| Mar 2019 | - | $441.00 K(-28.4%) |
| Dec 2018 | $616.00 K(+24.7%) | $616.00 K(-37.0%) |
| Sep 2018 | - | $978.00 K(+27.8%) |
| Jun 2018 | - | $765.00 K(-5.6%) |
| Mar 2018 | - | $810.00 K(+64.0%) |
| Dec 2017 | $494.00 K | $494.00 K(-45.2%) |
| Sep 2017 | - | $901.00 K(-17.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2017 | - | $1.09 M(-2.5%) |
| Mar 2017 | - | $1.12 M(+99.1%) |
| Dec 2016 | $563.00 K(-78.2%) | $563.00 K(-54.7%) |
| Sep 2016 | - | $1.24 M(-17.9%) |
| Jun 2016 | - | $1.51 M(-50.9%) |
| Mar 2016 | - | $3.08 M(+19.3%) |
| Dec 2015 | $2.58 M(+273.0%) | $2.58 M(+257.0%) |
| Sep 2015 | - | $724.00 K(-13.6%) |
| Jun 2015 | - | $838.00 K(+13.7%) |
| Mar 2015 | - | $737.00 K(+6.3%) |
| Dec 2014 | $693.00 K(+209.4%) | $693.00 K(+454.4%) |
| Sep 2014 | - | $125.00 K(-30.6%) |
| Jun 2014 | - | $180.00 K(-37.7%) |
| Mar 2014 | - | $289.00 K(+29.0%) |
| Dec 2013 | $224.00 K(-86.1%) | $224.00 K(+7.1%) |
| Sep 2013 | - | $209.10 K(-85.7%) |
| Jun 2013 | - | $1.46 M(-0.4%) |
| Mar 2013 | - | $1.47 M(+43.9%) |
| Sep 2012 | - | $1.02 M(-36.6%) |
| Jun 2012 | - | $1.61 M(+37.4%) |
| Mar 2012 | - | $1.17 M(-27.6%) |
| Dec 2011 | $1.62 M(+67.7%) | $1.62 M(-40.7%) |
| Sep 2011 | - | $2.73 M(+89.9%) |
| Jun 2011 | - | $1.44 M(+1642.1%) |
| Mar 2011 | - | $82.40 K(-91.5%) |
| Dec 2010 | $963.90 K | $963.90 K(+2410.2%) |
| Sep 2008 | - | $38.40 K(+7.6%) |
| Jun 2008 | - | $35.70 K(-1.4%) |
| Mar 2008 | - | $36.20 K |
FAQ
- What is Cocrystal Pharma annual accounts payable?
- What is the all time high annual accounts payable for Cocrystal Pharma?
- What is Cocrystal Pharma annual accounts payable year-on-year change?
- What is Cocrystal Pharma quarterly accounts payable?
- What is the all time high quarterly accounts payable for Cocrystal Pharma?
- What is Cocrystal Pharma quarterly accounts payable year-on-year change?
What is Cocrystal Pharma annual accounts payable?
The current annual accounts payable of COCP is $1.22 M
What is the all time high annual accounts payable for Cocrystal Pharma?
Cocrystal Pharma all-time high annual accounts payable is $2.58 M
What is Cocrystal Pharma annual accounts payable year-on-year change?
Over the past year, COCP annual accounts payable has changed by +$608.00 K (+99.02%)
What is Cocrystal Pharma quarterly accounts payable?
The current quarterly accounts payable of COCP is $859.00 K
What is the all time high quarterly accounts payable for Cocrystal Pharma?
Cocrystal Pharma all-time high quarterly accounts payable is $3.08 M
What is Cocrystal Pharma quarterly accounts payable year-on-year change?
Over the past year, COCP quarterly accounts payable has changed by +$291.00 K (+51.23%)